STORE SETUP Catalogue information and pricing are being finalised
Research use only ✦ Edinburgh Peptide ✦ Precision in every sequence
EPEDINBURGHPEPTIDEPRECISION IN EVERY SEQUENCE
Bag 0
Edinburgh Peptide

Blinding and the Measurement of Experimental Outcomes

Blinding and the Measurement of Experimental Outcomes

Knowledge can influence a measurement

Some experimental outcomes involve judgement: selecting an image region, deciding whether a sample meets an exclusion rule, or scoring a tissue section. Knowledge of group assignment can influence these decisions even when the researcher intends to be impartial. Blinding limits access to that knowledge during relevant tasks.

An apparently objective instrument does not remove every opportunity for judgement. Sample preparation, threshold selection and decisions about repeating a run can still affect the reported result. The question is where knowledge could influence the workflow, rather than whether the final number comes from a machine.

Describe the stage and the person

The phrase double blind is incomplete unless the paper explains whose knowledge was restricted. Participants, staff delivering an intervention, outcome assessors and analysts may have different levels of information. In animal experiments, a person preparing coded samples may know the allocation while the person scoring them does not.

The Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0 asks authors to describe awareness of allocation across experimental stages. A reading note should preserve that detail. Outcome assessment blinded is a more precise statement than a blanket claim that the whole experiment was blinded when only the scoring stage is described.

Look for a workable process

Imagine images from a peptide experiment are labelled only with neutral codes and presented in a shuffled order. The scorer applies a predefined rule before the code is revealed. This hypothetical process separates the judgement from knowledge of intervention, although the paper must still explain image selection and the scoring rule.

For human trials, the CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials provides reporting guidance about who was blinded and how. Some interventions cannot be concealed from everyone. In those circumstances, an independent blinded assessor or a clearly defined outcome may still reduce particular risks. Assess the reported safeguard rather than inferring failure from a label alone.

Interpret what is missing

If blinding is not reported, write that it is not reported. That is different from establishing that no blinding occurred. Conversely, a claim of blinding without implementation details does not show how the protection worked or whether obvious differences could reveal allocation.

For readers exploring our research material, a practical approach is to mark each stage as blinded, unblinded or unclear. Add the potential consequence beside it: selection, handling, assessment or analysis. This turns a vague quality judgement into a specific question about how much confidence to place in the measured comparison.

Related research reading

Explore the research blog and original batch-document library for further context.

Sources